New hip implant aims to cut repeat surgeries
NCT ID NCT04325022
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new hip implant called the OR3O Dual Mobility System in 177 people who need hip replacement surgery. The goal is to see if the implant is safe and lasts longer without needing another surgery. Researchers will follow participants for up to 10 years to check how well the implant holds up.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OR3O Dual Mobility hip implant (a medical device)
What this could lead to
If successful, this could provide a more durable hip replacement option that reduces the need for repeat surgeries.
What could go wrong
This is an early-stage study with only 177 participants, and long-term results are not yet available. Implants can fail or cause complications like infection or dislocation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED DEGENERATION OF THE HIP JOINT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Calvary John James Hospital
Deakin, 2600, Australia
-
Hospital for Special Surgery
New York, New York, 10021, United States
-
Mater Health Services
Brisbane, Queensland, 4101, Australia
-
NYU Langone Health
New York, New York, 10003, United States
-
Queen Mary Hospital
Hong Kong, 2255, Hong Kong
-
Royal Perth Hospital
Perth, Western Australia, 6000, Australia
-
South Health Campus, Calgary
Calgary, Alberta, T3M127, Canada
-
St Michael's Hospital
Toronto, Ontario, M5C1R6, Canada
-
St. David's Center for Hip and Knee Replacement
Austin, Texas, 78705, United States
-
University of Kentucky
Lexington, Kentucky, 40508, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 69198, United States
-
Wake Forest School of Medicine
Winston-Salem, North Carolina, 27157, United States